Suppr超能文献

及时的门诊就诊能否降低心力衰竭患者的再入院率和死亡率?

Can Timely Outpatient Visits Reduce Readmissions and Mortality Among Heart Failure Patients?

作者信息

Balasubramanian Ishwarya, Malhotra Chetna

机构信息

Duke-NUS Medical School, Lien Centre for Palliative Care, Singapore, Singapore.

Duke-NUS Medical School, Program in Health Services and Systems Research, Singapore, Singapore.

出版信息

J Gen Intern Med. 2024 Oct;39(13):2478-2486. doi: 10.1007/s11606-024-08755-1. Epub 2024 Apr 10.

Abstract

BACKGROUND

Outpatient follow-up after a hospital discharge may reduce the risk of readmissions, but existing evidence has methodological limitations.

OBJECTIVES

To assess effect of outpatient follow-up within 7, 14, 21 and 30 days of a hospital discharge on 30-day unplanned readmissions or mortality among heart failure (HF) patients; and whether this varies for patients with different clinical complexities.

DESIGN

We analyzed medical records between January 2016 and December 2021 from a prospective cohort study. Using time varying mixed effects parametric survival models, we examined the association between not having an outpatient follow-up and risk of adverse events. We used interaction models to assess if the effect of outpatient follow-up visit on outcomes varies with patients' clinical complexity (comorbidities, grip strength, cognitive impairment and length of inpatient stay).

PARTICIPANTS

Two hundred and forty-one patients with advanced HF.

MAIN MEASURES

30-day all-cause (or cardiac) adverse event defined as all cause (or cardiac) unplanned readmissions or death within 30 days of an unplanned all-cause (or cardiac) admission or emergency department visit.

KEY RESULTS

We analyzed 1595 all-cause admissions, inclusive of 1266 cardiac admissions. Not having an outpatient follow-up (vs having an outpatient follow-up) significantly increased the risk of 30-day all-cause adverse event. (risk [95% CI] - 14 days: 35.1 [84.5,-1.1]; 21 days: 43.9 [48.2,6.7]; 30 days: 31.1 [48.5, 7.9]) The risk (at 21 days) was higher for those with one co-morbidity (0.25 [0.11,0.58]), mild (0.67 [0.45, 1.00]) and moderate cognitive impairment (0.38 [0.17, 0.84]), normal grip strength (0.57 [0.34, 0.96]) and length of inpatient stay 7-13 days (0.45 [0.23, 0.89]).

CONCLUSION

Outpatient follow-up within 30 days after a hospital discharge reduced risk of 30-day adverse events among HF patients, the benefit varying according to clinical complexity. Results suggest the need to prioritize patients who benefit from outpatient follow-up for these visits.

摘要

背景

出院后的门诊随访可能会降低再入院风险,但现有证据存在方法学上的局限性。

目的

评估出院后7天、14天、21天和30天内的门诊随访对心力衰竭(HF)患者30天内非计划再入院或死亡率的影响;以及这对不同临床复杂性的患者是否有所不同。

设计

我们分析了一项前瞻性队列研究在2016年1月至2021年12月期间的医疗记录。使用时变混合效应参数生存模型,我们研究了未进行门诊随访与不良事件风险之间的关联。我们使用交互模型来评估门诊随访对结局的影响是否因患者的临床复杂性(合并症、握力、认知障碍和住院时间)而异。

参与者

241例晚期HF患者。

主要测量指标

30天全因(或心脏)不良事件定义为在非计划全因(或心脏)入院或急诊科就诊后30天内的所有原因(或心脏)非计划再入院或死亡。

关键结果

我们分析了1595例全因入院病例,包括1266例心脏入院病例。未进行门诊随访(与进行门诊随访相比)显著增加了30天全因不良事件的风险。(风险[95%置信区间] - 14天:35.1[84.5,-1.1];21天:43.9[48.2,6.7];30天:31.1[48.5,7.9])对于有1种合并症(0.25[0.11,0.58])、轻度(0.67[0.45,1.00])和中度认知障碍(0.38[0.17,0.84])、握力正常(0.57[0.34,0.96])且住院时间为7 - 13天(0.45[0.23,0.89])的患者,(21天时的)风险更高。

结论

出院后30天内的门诊随访降低了HF患者30天不良事件的风险,其益处因临床复杂性而异。结果表明需要对从门诊随访中获益的患者优先安排这些就诊。

相似文献

4
Antibiotics for the treatment of COVID-19.治疗 COVID-19 的抗生素。
Cochrane Database Syst Rev. 2021 Oct 22;10(10):CD015025. doi: 10.1002/14651858.CD015025.
7
Clinical service organisation for heart failure.心力衰竭的临床服务组织
Cochrane Database Syst Rev. 2012 Sep 12(9):CD002752. doi: 10.1002/14651858.CD002752.pub3.

引用本文的文献

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验